Valeant Pharmaceuticals to Hold Conference Call to Announce 2010 Financial Guidance

January 05, 2010

Valeant Pharmaceuticals to Hold Conference Call to Announce 2010 Financial Guidance

ALISO VIEJO, Calif., Jan 05, 2010 /PRNewswire-FirstCall via COMTEX/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Friday, January 8, 2010 at 9:00 a.m. EST (6:00 a.m. PST) to announce 2010 financial guidance.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081125/VALEANTLOGO)

The dial-in number to participate on this call is (877) 295-5743, confirmation code 49447828. International callers should dial (973) 200-3961, confirmation code 49447828. A replay will be available approximately two hours following the conclusion of the conference call to Friday, January 15, 2010, and can be accessed by dialing (800) 642-1687 or (706) 645-9291, confirmation code 49447828.

The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at www.valeant.com. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at http://www.valeant.com/.

About Valeant

Valeant Pharmaceuticals International (NYSE: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at http://www.valeant.com/.

Contact:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

SOURCE Valeant Pharmaceuticals International

http://www.valeant.com